L7 Informatics Automates Lab Operations and Supports Washington University School of Medicine with Workflow for Its Saliva-based COVID-19 Test
AUSTIN, Texas, Nov. 9, 2020 /PRNewswire/ — L7 Informatics announced that it has deployed L7|ESP to automate all lab operations starting with COVID-related workflow at the Genome Technology Access Center ([email protected]) in the McDonnell Genome Institute at the Washington University School of Medicine. The COVID-related workflow supports the new saliva test, developed by Washington University researchers, that is used to detect the SARS-CoV-2 virus.
L7|ESP is CLIA (Clinical Laboratory Improvement Amendments) compliant and enables diagnostic organizations to use a single platform for registering and processing samples, running complex analyses, generating reports, and provides complete end-to-end assay automation. L7|ESP is designed to increase reproducibility and efficiency while decreasing errors and turnaround time.
According to L7 Informatics President and CEO, Vasu Rangadass, Ph.D., “L7|ESP will enable the COVID-related workflow at Washington University’s McDonnell Genome Institute (MGI) to scale to 10,000 samples per week if need be, and this ability to scale-up could help support the number of tests that can be conducted.”
L7 carried out the content implementation at GTAC in four releases. The main tasks performed as part of this project include Sample Accessioning, Saliva Processing, RT/STA, Prepare and Load IFC Plate, Analysis/ Reporting, Inventory App, Protocols/workflows/workflow chain configs, and Locations App.
Richard Head, a professor of genetics and director of the Genome Technology Access Center at the McDonnell Genome Institute, added, “This is a COVID-19 test process that can be used at scale, and it is essential that test results are reproducible and samples can be processed efficiently. We have used L7’s ESP technology to help us reach that goal.”
About L7 Informatics
The L7 mission is to revolutionize the scientific process by streamlining process and data management and thereby accelerate precision health across life sciences, healthcare, and food value-chains. L7 Informatics provides software and services that enable synchronized solutions for scientific research and development. For more information, visit www.L7informatics.com.
L7 Informatics, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/l7-informatics-automates-lab-operations-and-supports-washington-university-school-of-medicine-with-workflow-for-its-saliva-based-covid-19-test-301168894.html
SOURCE L7 Informatics, Inc.
ROCKVILLE, MD — The Rockville lab ordered by the state to stop processing COVID-19 tests following an investigation into its protocols has been cleared to resume testing, the company announced Wednesday.
“I am pleased that AdvaGenix is approved to resume COVID-19 testing by the Centers for Medicare and Medicaid Services and the Maryland Department of Health,” said AdvaGenix owner Dr. William Kearns. “AdvaGenix has confirmed the integrity of the specimens and accuracy of the tests we’ve conducted.”
AdvaGenix, once the largest supplier of COVID-19 tests for Montgomery County, had to halt testing after state and federal officials visited the lab in August and found deficient practices.
Health officials did not go into specifics but said investigators found “improper laboratory and COVID-19 testing procedures that endanger patient health, safety, and welfare.”
Montgomery County cut ties with the lab shortly thereafter.
Kearns disputed the investigation, saying that the tests were safe and accurate — and that the issues investigators found had to do with a “pre-analytical temperature stability study.”
Before being ordered to stop, AdvaGenix had processed more than 19,000 tests — or roughly 8 percent of the total testing provided to county residents.
After cutting ties with AdvaGenix, the county inked a deal with CIAN Diagnostic Laboratories in Frederick.
Dr. Travis Gayles, the county’s top health official, said the county recently had a conversation with AdvaGenix about its services.
“At this time, based upon our current needs, we have the (testing) capacity but, consistent with what we’ve always said, we continue to explore new partnerships, particularly if there are new opportunities for new technology to integrate into the systems that we have,” he said. “So that’s where we currently stand with AdvaGenix, as well as with other companies that could potentially be able to meet those needs as they arise in the future.”
The county is consistently meeting its goal to test 5 percent of its population per month.
This article originally appeared on the Rockville Patch
Flu shots are already considered an important factor in combating the coronavirus pandemic, since widespread inoculations will hopefully help prevent medical facilities from becoming overwhelmed by dual diseases. But new research suggests flu shots may also play some role in preventing COVID-19 infections in the first place, The Scientific American reports.
A study, which has not yet been peer-reviewed, found that workers at Radboud University Medical Center in the Netherlands who received a flu shot during the 2019-20 season were 39 percent less likely than their colleagues to test positive for the coronavirus as of June 1, 2020. Non-vaccinated employees contracted the virus at a 2.23 percent rate, compared to only 1.33 percent of those who were vaccinated.
The preliminary research would certainly require further clinical trials — though the author of the study noted it would be unethical to compel a control group of subjects to be denied a flu shot — and there could be several reasons why the vaccinated group staved off infection more easily, including the possibility that they are generally more health conscious and took more COVID-19 precautions.
Still, there have been other studies that hint at a possible link between flu shots (and other vaccines, for that matter) and lower COVID-19 risk. Additionally, the Radboud research team conducted a laboratory experiment in which they took blood cells from healthy individuals, purified them, and exposed some of them to a flu vaccine. After allowing the cells to grow for a few days, the researchers exposed them to the coronavirus. A day later they found that the vaccinated cells produced more of several kinds of immune molecules that fight off pathogens than those that were initially left alone. Read more at The Scientific American.
More stories from theweek.com
How to make an election crisis
64 things President Trump has said about women
Republicans are on the verge of a spectacular upside-down achievement
ALBUQUERQUE, N.M. (AP) — New Mexico Gov. Michelle Lujan Grisham is scheduled Tuesday to provide an update on COVID-19 cases after a string of record-breaking daily case counts prompted more restrictions last week and officials continue to crack down on employers who they say aren’t following the rules.
The state’s Occupational Health and Safety Bureau has opened an investigation of Sandia National Laboratories after receiving a complaint about alleged violations of the state public health order.… Read More
Tencent Announces AIMIS Medical Image Cloud and AIMIS Open Lab Help Medical Data Management and Accelerate Incubation of Medical AI Application
New offering will enhance medical imaging management by patients and sharing between healthcare professionals, driving the digital transformation of the world’s medical and healthcare industries. In conjunction with this offering, Tencent created the AI Open lab as a one-stop intelligent service platform to provide clinicians and technology enterprises with the necessary tools to handle critical medical data and diagnose patients.
SHANGHAI, Oct. 20, 2020 /PRNewswire/ — Today, Tencent announced at the 83rd China International Medical Device Expo (CMEF) two new products that will enable consumers and medical professionals to safely and securely share medical data more easily, and equip medical professionals new tools to diagnose patients and achieve better patient outcomes. The Tencent AIMIS Medical Image Cloud, where patients can manage their images generated by X-rays, CT, and MRIs to allow for safe and secure sharing of patient medical data. The second product, The Tencent AIMIS Open Lab will share Tencent’s medical AI capabilities with third parties, including scientific research institutions, universities, and scientific and technological innovation enterprises, to incubate medical AI applications.
Tencent AIMIS Image Cloud supports complete images on the cloud to reduce repeated examination
It is often inconvenient and cumbersome for patients to manage their medical images and share them with medical professionals. Therefore, patients often cannot provide complete medical information during a medical review, which makes it difficult to support further diagnosis and often requires a patient to repeat the examination.
Patients can now safely manage their images via Tencent AIMIS Image Cloud and can permission medical professionals’ access to the original images and reports anytime, anywhere. Patients can carry out one-stop management of personal data and authorize the sharing and mutual recognition of image reports among hospitals, so that the complete medical image files can be checked to avoid unnecessary duplicate examinations and reduce the waste of medical resources.
In addition, the Tencent AIMIS Image Cloud also connects medical institutions at all levels in the Medical Treatment Combination through Picture Archiving and Communication Systems (PACS) on the cloud, so patients can take examinations in primary medical institutions and obtain expert diagnosis remotely. Doctors can conduct online consultations through Tencent real-time audio and video facilities when they encounter difficult cases and they can conduct synchronous collaborative operations on images to communicate efficiently.
Tencent AIMIS Open Lab accelerates Incubation of medical AI application
In the field of medical AI, scientific research institutes, medical institutions, and technology startups are generally faced with pain points, such as a lack of data sources, time-consuming labeling, a lack of applicable algorithms, and difficulties meeting the required computing power. Tencent AIMIS Open Lab is a one-stop intelligent service platform grounded in secure storage and the compelling computing power of the Tencent cloud. Tencent AIMIS Open Lab provides clinicians and technology enterprises with whole-process services such as data desensitization, access, annotation, the ability to model training, testing and applying, they can develop medical AI applications more efficiently, so as to promote
- Researchers surveyed people in five countries to assess which coronavirus-related conspiracy theories have taken root.
- The most popular theory suggests the virus was “bioengineered in a laboratory in Wuhan.” Between 22% and 23% of Americans and Britons viewed that as “reliable.”
- The study found that people who are older, numerically savvy, and trust scientists are less likely to fall for coronavirus misinformation.
- Genetic evidence discredits the theory that the coronavirus was man-made.
- Visit Business Insider’s homepage for more stories.
Lingering uncertainty how the coronavirus pandemic started creates fertile territory for conspiracy theories.
About one in four Americans and Britons think the idea that the virus was engineered in a Wuhan laboratory is a “reliable” claim, according to a recent study, despite abundant scientific evidence to the contrary.
The research, published earlier this week in the journal Royal Society for Open Science, found that an even higher portion of respondents in Ireland and Spain — 26% and 33%, respectively — put stock in that theory, as do nearly 40% of survey participants in Mexico.
“Certain misinformation claims are consistently seen as reliable by substantial sections of the public,” Sander van der Linden, a co-author of the new study and a social psychologist at the University of Cambridge, said in a press release.
What’s more, people who found the lab conspiracy idea reliable were generally more hesitant about getting a coronavirus vaccine.
“We find a clear link between believing coronavirus conspiracies and hesitancy around any future vaccine,” van der Linden added.
People who trust scientists are less likely to fall for misinformation
The study authors sent an online survey to groups of 700 people in the US, Mexico, Ireland, and Spain, and to more than 1,000 people in the UK. They asked participants to rate how reliable certain statements about COVID-19 were on a scale of 1 to 7, and also asked about participants’ attitudes about a vaccine.
The researchers wanted to assess whether certain beliefs or demographics are correlated with how susceptible a person is to misinformation.
The results showed that respondents with “significantly and consistently” low levels of susceptibility to false information in all five countries also declared they trusted scientists and scored highly on a series of tasks designed to test their understanding of probability. Being older was linked to lower susceptibility to misinformation as well, in every country surveyed except Mexico.
Additionally, those who reported trusting their politicians to effectively tackle the crisis in Mexico, Spain, and the US were more likely to fall for conspiracy theories.
The study also found that respondents in Ireland, the UK, and the US who were exposed to coronavirus information on social media were more susceptible to misinformation.
Van der Linden’s team also found that as participants’ susceptibility increased, their intent to get vaccinated or recommend the vaccine to friends